Zeyu Li

591 total citations
35 papers, 414 citations indexed

About

Zeyu Li is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Zeyu Li has authored 35 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Zeyu Li's work include Liver Disease Diagnosis and Treatment (5 papers), Mitochondrial Function and Pathology (3 papers) and Liver Disease and Transplantation (3 papers). Zeyu Li is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Mitochondrial Function and Pathology (3 papers) and Liver Disease and Transplantation (3 papers). Zeyu Li collaborates with scholars based in China, United States and Hong Kong. Zeyu Li's co-authors include Jingyao Zhang, Kai Qu, Yifan Jia, Chang Liu, Ruixia Cui, Yang Feng, Peiqing Liu, Xia Zhang, Xing Zhang and Xiaolei Zhang and has published in prestigious journals such as Circulation Research, Biochemical and Biophysical Research Communications and Journal of Ethnopharmacology.

In The Last Decade

Zeyu Li

30 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeyu Li China 13 206 62 47 45 42 35 414
Wei Xing China 11 191 0.9× 118 1.9× 33 0.7× 52 1.2× 31 0.7× 38 428
Junmei Ye China 14 223 1.1× 63 1.0× 27 0.6× 48 1.1× 21 0.5× 27 431
Weiwei Qin China 15 192 0.9× 44 0.7× 28 0.6× 59 1.3× 41 1.0× 42 497
Yanqing Chi China 13 259 1.3× 109 1.8× 49 1.0× 36 0.8× 23 0.5× 23 577
Weijin Fang China 10 224 1.1× 106 1.7× 64 1.4× 32 0.7× 25 0.6× 39 525
Wei Ai China 12 354 1.7× 80 1.3× 60 1.3× 45 1.0× 56 1.3× 22 698
Yaqi Xing China 4 243 1.2× 64 1.0× 45 1.0× 48 1.1× 20 0.5× 7 425
Zhenfeng Chen China 10 227 1.1× 112 1.8× 20 0.4× 86 1.9× 28 0.7× 26 438
Hongyan Zhang China 12 135 0.7× 65 1.0× 40 0.9× 18 0.4× 25 0.6× 34 387
Yunfeng Hou China 12 216 1.0× 53 0.9× 60 1.3× 53 1.2× 63 1.5× 19 496

Countries citing papers authored by Zeyu Li

Since Specialization
Citations

This map shows the geographic impact of Zeyu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeyu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeyu Li more than expected).

Fields of papers citing papers by Zeyu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeyu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeyu Li. The network helps show where Zeyu Li may publish in the future.

Co-authorship network of co-authors of Zeyu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zeyu Li. A scholar is included among the top collaborators of Zeyu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeyu Li. Zeyu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Tingting, Bing Liu, Ping Yang, et al.. (2025). Effects of Different Linezolid Concentration Levels on Hematologic Side Effects: A New Target for Therapeutic Drug Monitoring. Therapeutic Drug Monitoring. 47(6). e104–e111.
2.
Li, Zeyu, Guoying Wang, Xiumei Hong, et al.. (2025). Prenatal Per‐ and Polyfluoroalkyl Substance Exposures and Longitudinal Blood Pressure Measurements in Children Aged 3 to 18 Years: Findings From a Racially and Ethnically Diverse US Birth Cohort. Journal of the American Heart Association. 14(12). e039949–e039949. 1 indexed citations
3.
Li, Zeyu, Suiqing Huang, Huayang Li, et al.. (2025). PERK's novel agonist protects against myocardial ischemia-reperfusion injury by modulating ER-mitochondria contacts and phosphatidic acid transport. International Journal of Cardiology. 431. 133222–133222.
4.
Guo, Zhen, Huimin Liang, Zeyu Li, et al.. (2025). GPLD1 Attenuates Heart Failure via Dual-Membrane Localization to Inhibit uPAR. Circulation Research. 137(5). e124–e143.
5.
Li, Zeyu, Suiqing Huang, Jingxuan Zhang, et al.. (2025). Thymoquinone alleviates myocardial ischemia/reperfusion injury by stabilizing mitochondria-associated membrane homeostasis via targeting ATAD3A. Phytomedicine. 143. 156914–156914.
6.
Wu, Changbu, Zeyu Li, Jiachen Li, et al.. (2025). SLAMF7 regulates goblet cell mucus production and negatively impacts gut homeostasis and commensalism. Gut Microbes. 17(1). 2527857–2527857. 1 indexed citations
7.
Li, Zeyu, et al.. (2024). Identification, characterization and complete genome analysis of a Vibrio anguillarum isolated from Sebastes schlegelii. Microbial Pathogenesis. 190. 106611–106611. 7 indexed citations
9.
Wang, Minghui, Yan-qing Ding, Yuehuai Hu, et al.. (2023). SIRT3 improved peroxisomes-mitochondria interplay and prevented cardiac hypertrophy via preserving PEX5 expression. Redox Biology. 62. 102652–102652. 18 indexed citations
11.
Li, Zeyu, Erwei Hao, Rui Cao, et al.. (2022). Analysis on internal mechanism of zedoary turmeric in treatment of liver cancer based on pharmacodynamic substances and pharmacodynamic groups. Chinese Herbal Medicines. 14(4). 479–493. 12 indexed citations
12.
Ouyang, Shumin, Qiyi Zhang, Linlin Lou, et al.. (2022). The Double-Edged Sword of SIRT3 in Cancer and Its Therapeutic Applications. Frontiers in Pharmacology. 13. 871560–871560. 23 indexed citations
14.
Zhang, Ting, Limei Sun, Songshan Li, et al.. (2021). Mydriasis-Free Flicker Electroretinograms in 204 Healthy Children Aged 0–18 Years: Reference Data From Two Cohorts. Translational Vision Science & Technology. 10(13). 7–7. 4 indexed citations
15.
Zhang, Xu, et al.. (2020). Evodiamine via targeting nNOS and AMPA receptor GluA1 inhibits nitroglycerin-induced migraine-like response. Journal of Ethnopharmacology. 254. 112727–112727. 9 indexed citations
16.
Yu, Xin, et al.. (2020). A brief discussion on evidence-based clinical research of traditional Chinese medicine. Annals of Palliative Medicine. 10(12). 12937–12944. 6 indexed citations
17.
Wang, Panxia, Rui Lan, Zhen Guo, et al.. (2020). Histone Demethylase JMJD3 Mediated Doxorubicin-Induced Cardiomyopathy by Suppressing SESN2 Expression. Frontiers in Cell and Developmental Biology. 8. 548605–548605. 24 indexed citations
18.
Zhang, Xing, Runchen Miao, Tian Liu, et al.. (2019). IDH1 as a frequently mutated gene has potential effect on exosomes releasement by epigenetically regulating P2RX7 in intrahepatic cholangiocarcinoma. Biomedicine & Pharmacotherapy. 113. 108774–108774. 14 indexed citations
19.
Feng, Yang, Ruixia Cui, Zeyu Li, et al.. (2019). Methane Alleviates Acetaminophen-Induced Liver Injury by Inhibiting Inflammation, Oxidative Stress, Endoplasmic Reticulum Stress, and Apoptosis through the Nrf2/HO-1/NQO1 Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2019. 1–14. 86 indexed citations
20.
Tian, Ye, et al.. (2013). Androgen receptor may be responsible for gender disparity in gastric cancer. Medical Hypotheses. 80(5). 672–674. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026